Skip NavigationSkip to Content
Return Return to Search Results

Recognition and Management of Significant Drug Interactions in HIV Patients: Challenges in Using Available Data to Guide Therapy

  1. Author:
    Pau, A. K.
    Boyd, S. D.

  2. Author Address

    [Pau, A. K.] NIAID, Div Clin Res, NIH, Bethesda, MD 20892 USA. [Boyd, S. D.] SAIC Frederick Inc, Natl Canc Inst Frederick, Frederick, MD USA.;Pau, AK, NIAID, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.;apau@niaid.nih.gov
    1. Year: 2010
    2. Date: Nov
  2. Journal: Clinical Pharmacology & Therapeutics
    1. 88
    2. 5
    3. Pages: 712-719
  4. Type of Article: Article
  5. ISSN: 0009-9236
  1. Abstract:

    Combination antiretroviral therapy (cART) has improved survival rates in HIV-infected patients; however, patients now experience comorbidities that require pharmacological intervention, thereby increasing the risk of drug-drug interactions (DDIs). HIV protease inhibitors (PIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and the CCR5 antagonist maraviroc are primarily metabolized via the cytochrome P450 (CYP) system and are prone to pharmacokinetic interactions.(1,2) This article addresses some key challenges that prescribers face when using available drug interaction-data resources in making day-to-day clinical decisions.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1038/clpt.2010.130
  3. View record in Web of Science®
  4. WOS: 000283296500030

Library Notes

  1. Fiscal Year: FY2010-2011
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel